These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7862860)

  • 1. Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional responses in anxiety models in rodents.
    Griebel G; Moreau JL; Jenck F; Misslin R; Martin JR
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):463-70. PubMed ID: 7862860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in Anxiety-Like Behavior within a Batch of Wistar Rats Are Associated with Differences in Serotonergic Transmission, Enhanced by Acute SRI Administration, and Abolished By Serotonin Depletion.
    Näslund J; Studer E; Pettersson R; Hagsäter M; Nilsson S; Nissbrandt H; Eriksson E
    Int J Neuropsychopharmacol; 2015 Feb; 18(8):. PubMed ID: 25716782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 8-OH-DPAT, but not deramciclane, antagonizes the anxiogenic-like action of paroxetine in an elevated plus-maze.
    Kõks S; Beljajev S; Koovit I; Abramov U; Bourin M; Vasar E
    Psychopharmacology (Berl); 2001 Jan; 153(3):365-72. PubMed ID: 11271409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and chronic effects of gepirone and fluoxetine in rats tested in the elevated plus-maze: an ethological analysis.
    Silva RC; Brandão ML
    Pharmacol Biochem Behav; 2000 Feb; 65(2):209-16. PubMed ID: 10672971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The differential effects of chronic imipramine or citalopram administration on physiological and behavioral outcomes in naïve mice.
    Strekalova T; Anthony DC; Dolgov O; Anokhin K; Kubatiev A; Steinbusch HM; Schroeter C
    Behav Brain Res; 2013 May; 245():101-6. PubMed ID: 23434605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin reuptake inhibition by citalopram in rat strains differing for their emotionality.
    Pollier F; Sarre S; Aguerre S; Ebinger G; Mormède P; Michotte Y; Chaouloff F
    Neuropsychopharmacology; 2000 Jan; 22(1):64-76. PubMed ID: 10633492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression.
    Wesołowska A; Nikiforuk A
    Neuropharmacology; 2007 Apr; 52(5):1274-83. PubMed ID: 17320917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram.
    Arborelius L; Nomikos GG; Hertel P; Salmi P; Grillner P; Höök BB; Hacksell U; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):630-40. PubMed ID: 8738296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anxiolytic effects of serotonin reuptake inhibitors and their mechanism of action].
    Hashimoto S
    Hokkaido Igaku Zasshi; 2000 Nov; 75(6):421-36. PubMed ID: 11193934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of combined administration of 5-HT1A or 5-HT1B/1D receptor antagonists and antidepressants in the forced swimming test.
    Tatarczyńska E; Kłodzińska A; Stachowicz K; Chojnacka-Wójcik E
    Eur J Pharmacol; 2004 Mar; 487(1-3):133-42. PubMed ID: 15033385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
    Millan MJ; Dekeyne A; Papp M; La Rochelle CD; MacSweeny C; Peglion JL; Brocco M
    J Pharmacol Exp Ther; 2001 Aug; 298(2):581-91. PubMed ID: 11454919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrasting effects of acute and chronic treatment with imipramine and fluoxetine on inhibitory avoidance and escape responses in mice exposed to the elevated T-maze.
    Gomes KS; de Carvalho-Netto EF; Monte KC; Acco B; Nogueira PJ; Nunes-de-Souza RL
    Brain Res Bull; 2009 Mar; 78(6):323-7. PubMed ID: 19047015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral effects of acute and chronic imipramine in the elevated T-maze model of anxiety.
    Teixeira RC; Zangrossi H; Graeff FG
    Pharmacol Biochem Behav; 2000 Apr; 65(4):571-6. PubMed ID: 10764908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anxiogenic-like effect of serotonin(1B) receptor stimulation in the rat elevated plus-maze.
    Lin D; Parsons LH
    Pharmacol Biochem Behav; 2002 Apr; 71(4):581-7. PubMed ID: 11888549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurokinin1 antagonists potentiate antidepressant properties of serotonin reuptake inhibitors, yet blunt their anxiogenic actions: a neurochemical, electrophysiological, and behavioral characterization.
    Gobert A; Brocco M; Dekeyne A; Di Cara B; Bouchez G; Lejeune F; Gannon RL; Millan MJ
    Neuropsychopharmacology; 2009 Mar; 34(4):1039-56. PubMed ID: 18830239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive allosteric modulation of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptors differentially modulates the behavioural effects of citalopram in mouse models of antidepressant and anxiolytic action.
    Fitzpatrick CM; Larsen M; Madsen LH; Caballero-Puntiverio M; Pickering DS; Clausen RP; Andreasen JT
    Behav Pharmacol; 2016 Sep; 27(6):549-55. PubMed ID: 27341500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and chronic citalopram treatment differently modulates rat exploratory behavior in the exploration box test: no evidence for increased anxiety or changes in the [3H]raclopride binding.
    Matto V; Allikmets L
    Pharmacology; 1999 Feb; 58(2):59-69. PubMed ID: 9873231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk assessment behaviour: evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test.
    Griebel G; Rodgers RJ; Perrault G; Sanger DJ
    Pharmacol Biochem Behav; 1997 Aug; 57(4):817-27. PubMed ID: 9259011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perinatal exposure to the selective serotonin reuptake inhibitor citalopram alters spatial learning and memory, anxiety, depression, and startle in Sprague-Dawley rats.
    Sprowles JL; Hufgard JR; Gutierrez A; Bailey RA; Jablonski SA; Williams MT; Vorhees CV
    Int J Dev Neurosci; 2016 Nov; 54():39-52. PubMed ID: 27591973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wistar-Kyoto rats are sensitive to the hypolocomotor and anxiogenic effects of mCPP.
    Durand M; Mormède P; Chaouloff F
    Behav Pharmacol; 2003 Mar; 14(2):173-7. PubMed ID: 12658079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.